Family Medicine Doctors in Monsey, NY Accepting Medicare

6 Family Medicine doctors found. Showing 1 - 6

Dr. David Benjamin Simons, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2 Crestview Ter, Monsey, NY 10952 Phone: 845-425-8300    Fax: 845-356-7077

Jacob Fekete, NP Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 22 Cameo Ridge Rd, Monsey, NY 10952 Phone: 845-662-6953

Dr. Johannes D Weltin, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 38 Glenbrook Rd, Monsey, NY 10952 Phone: 845-354-9300    Fax: 845-354-9448

Juliet Ovshayev, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6 Melnick Dr., Suite 101, Monsey, NY 10952 Phone: 845-352-9292    Fax: 845-352-1252

Dr. Issac D. Wurzburger, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 8 Dover Ter, Monsey, NY 10952 Phone: 845-425-4488    Fax: 845-425-4492

Robi Rosenfeld, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 40 Robert Pitt Dr, Monsey, NY 10952 Phone: 845-352-6800    Fax: 845-352-7293

News Archive

European Commission and Japan approve once-daily dual bronchodilator Ultibro Breezhaler (QVA149) nearly simultaneously, for COPD patients

Novartis announced today that the European Commission approved once-daily Ultibro® Breezhaler® (indacaterol 85 mcg / glycopyrronium 43 mcg) as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD). In addition, the Japanese Ministry of Health, Labour and Welfare (MHLW) approved once-daily Ultibro® Inhalation Capsules (glycopyrronium 50 mcg / indacaterol 110 mcg), delivered through the Breezhaler® device, for relief of various symptoms due to airway obstruction in chronic obstructive pulmonary disease (COPD). Ultibro® Breezhaler® / Ultibro® Inhalation Capsules were developed under the name QVA149.

Major depression reduces success rate of quitting smoking

Depressed smokers want to quit the nicotine habit just as much as non-depressed smokers, but a new study suggests that depression can put a kink in their success.

Public service announcement encourages people to get tested for glaucoma

Upstate Medical University has produced a public service announcement that calls attention to the importance of being tested for glaucoma, the second leading cause of blindness in the world, according to the World Health Organization.

Risperidone recall by J&J

Ortho-McNeil-Janssen Pharmaceuticals Inc., a unit of Johnson & Johnson, recalled about 16,000 bottles of its Risperdal schizophrenia drug on reports of an uncharacteristic odor. The recall affects one lot that was shipped between Aug. 27, 2010, and Feb. 15, 2011.

Knee replacement operations have more than doubled in a decade

The findings are based on an analysis of hospital treatment statistics in England between 1991 and 2000. The number of first time hip replacements increased by 18% during this period, while the need to revise the procedure more than doubled.

Read more Medical News

› Verified 4 days ago